Inhibitor Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Inhibitor Therapeutics, Inc. (INTI) had Deferred Tax Assets, Operating Loss Carryforwards of $4.61 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.61M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.04M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.52M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.87M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $4.61M 10-K · filed 2026-03-26 |
| 2024-12-31 | $4.04M 10-K · filed 2026-03-26 |
| 2023-12-31 | $3.52M 10-K · filed 2025-03-28 |
| 2022-12-31 | $3.87M 10-K · filed 2024-03-29 |
| 2021-12-31 | $6.69M 10-K · filed 2023-03-31 |
| 2020-12-31 | $6.61M 10-K · filed 2021-03-26 |
| 2020-12-12 | $6.61M 10-K · filed 2022-03-30 |
| 2019-12-31 | $6.43M 10-K · filed 2021-03-26 |
| 2018-12-31 | $5.81M 10-K · filed 2020-03-30 |
| 2017-12-31 | $4.76M 10-K · filed 2019-03-07 |
| 2016-12-31 | $3.00M 10-K · filed 2018-02-16 |
| 2015-12-31 | $1.68M 10-K · filed 2017-02-17 |
| 2014-12-31 | $878.71K 10-K · filed 2016-02-01 |
| 2013-12-31 | $407.40K 10-K · filed 2015-02-13 |
| 2012-12-31 | $15.99M 10-K · filed 2014-04-15 |